KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to $2.1 million.

  • Emergent BioSolutions' Other Working Capital Changes fell 8467.15% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$50.7 million, marking a year-over-year increase of 7124.22%. This contributed to the annual value of -$169.9 million for FY2024, which is 135213.68% down from last year.
  • Per Emergent BioSolutions' latest filing, its Other Working Capital Changes stood at $2.1 million for Q3 2025, which was down 8467.15% from -$19.7 million recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Other Working Capital Changes ranged from a high of $400.0 million in Q3 2021 and a low of -$140.3 million during Q2 2024
  • Over the past 5 years, Emergent BioSolutions' median Other Working Capital Changes value was -$7.6 million (recorded in 2021), while the average stood at $6.7 million.
  • Data for Emergent BioSolutions' Other Working Capital Changes shows a peak YoY increase of 264000.0% (in 2024) and a maximum YoY decrease of 63549.62% (in 2024) over the last 5 years.
  • Over the past 5 years, Emergent BioSolutions' Other Working Capital Changes (Quarter) stood at -$86.6 million in 2021, then skyrocketed by 83.37% to -$14.4 million in 2022, then plummeted by 108.33% to -$30.0 million in 2023, then grew by 21.33% to -$23.6 million in 2024, then surged by 108.9% to $2.1 million in 2025.
  • Its Other Working Capital Changes was $2.1 million in Q3 2025, compared to -$19.7 million in Q2 2025 and -$9.5 million in Q1 2025.